SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-324570
Filing Date
2020-12-22
Accepted
2020-12-22 16:30:50
Documents
12
Period of Report
2020-12-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d48029d8k.htm   iXBRL 8-K 25095
  Complete submission text file 0001193125-20-324570.txt   147509

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tbio-20201221.xsd EX-101.SCH 3061
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbio-20201221_lab.xml EX-101.LAB 18123
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbio-20201221_pre.xml EX-101.PRE 11399
5 EXTRACTED XBRL INSTANCE DOCUMENT d48029d8k_htm.xml XML 3336
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38550 | Film No.: 201408267
SIC: 2836 Biological Products, (No Diagnostic Substances)